156 related articles for article (PubMed ID: 8999897)
1. Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.
Hoshi M; Takashima A; Murayama M; Yasutake K; Yoshida N; Ishiguro K; Hoshino T; Imahori K
J Biol Chem; 1997 Jan; 272(4):2038-41. PubMed ID: 8999897
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
Hoshi M; Takashima A; Noguchi K; Murayama M; Sato M; Kondo S; Saitoh Y; Ishiguro K; Hoshino T; Imahori K
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2719-23. PubMed ID: 8610107
[TBL] [Abstract][Full Text] [Related]
3. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.
Roher AE; Chaney MO; Kuo YM; Webster SD; Stine WB; Haverkamp LJ; Woods AS; Cotter RJ; Tuohy JM; Krafft GA; Bonnell BS; Emmerling MR
J Biol Chem; 1996 Aug; 271(34):20631-5. PubMed ID: 8702810
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.
Pedersen WA; Kloczewiak MA; Blusztajn JK
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):8068-71. PubMed ID: 8755604
[TBL] [Abstract][Full Text] [Related]
5. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices.
Kar S; Seto D; Gaudreau P; Quirion R
J Neurosci; 1996 Feb; 16(3):1034-40. PubMed ID: 8558231
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β peptide increases cell surface localization of α7 ACh receptor to protect neurons from amyloid β-induced damage.
Jin Y; Tsuchiya A; Kanno T; Nishizaki T
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):157-60. PubMed ID: 26522221
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.
Kar S; Issa AM; Seto D; Auld DS; Collier B; Quirion R
J Neurochem; 1998 May; 70(5):2179-87. PubMed ID: 9572306
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ
Zhang X; Wang X; Hu X; Chu X; Li X; Han F
Phytomedicine; 2019 Apr; 57():331-338. PubMed ID: 30807987
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats.
Vaucher E; Aumont N; Pearson D; Rowe W; Poirier J; Kar S
J Chem Neuroanat; 2001 Jun; 21(4):323-9. PubMed ID: 11429273
[TBL] [Abstract][Full Text] [Related]
13. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori K; Uchida T
J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease.
Bobba A; Amadoro G; Petragallo VA; Calissano P; Atlante A
Biochim Biophys Acta; 2013 Jul; 1827(7):848-60. PubMed ID: 23583906
[TBL] [Abstract][Full Text] [Related]
15. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta.
Takashima A; Noguchi K; Michel G; Mercken M; Hoshi M; Ishiguro K; Imahori K
Neurosci Lett; 1996 Jan; 203(1):33-6. PubMed ID: 8742040
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
17. Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs.
Szutowicz A; Bielarczyk H; Gul S; Ronowska A; Pawełczyk T; Jankowska-Kulawy A
Metab Brain Dis; 2006 Sep; 21(2-3):149-61. PubMed ID: 16724269
[TBL] [Abstract][Full Text] [Related]
18. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.
Zhang Y; McLaughlin R; Goodyer C; LeBlanc A
J Cell Biol; 2002 Feb; 156(3):519-29. PubMed ID: 11815632
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-CoA metabolism in cholinergic neurons and their susceptibility to neurotoxic inputs.
Szutowicz A; Tomaszewicz M; Jankowska A; Madziar B; Bielarczyk H
Metab Brain Dis; 2000 Mar; 15(1):29-44. PubMed ID: 10885539
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
